AptarGroup Inc. (ATR)
145.97
1.86 (1.29%)
At close: Apr 14, 2025, 3:22 PM
1.29% (1D)
| Bid | 145.64 |
| Market Cap | 9.63B |
| Revenue (ttm) | 3.58B |
| Net Income (ttm) | 374.54M |
| EPS (ttm) | 5.53 |
| PE Ratio (ttm) | 26.4 |
| Forward PE | 27.17 |
| Analyst | Buy |
| Ask | 146.24 |
| Volume | 118,183 |
| Avg. Volume (20D) | 388,904 |
| Open | 145.80 |
| Previous Close | 144.11 |
| Day's Range | 144.11 - 146.27 |
| 52-Week Range | 130.85 - 178.03 |
| Beta | 0.59 |
About ATR
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Apr 23, 1993
Employees 13,500
Stock Exchange NYSE
Ticker Symbol ATR
Website https://www.aptar.com
Analyst Forecast
According to 5 analyst ratings, the average rating for ATR stock is "Buy." The 12-month stock price forecast is $180, which is an increase of 23.31% from the latest price.
Stock ForecastsNext Earnings Release
AptarGroup Inc. is scheduled to release its earnings on May 1, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-8.48%
AptarGroup shares are trading lower after the comp...
Unlock content with
Pro Subscription
6 months ago
+3.49%
AptarGroup shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $155 to $215.
